Puma Biotechnology (PBYI) Net Margin (2017 - 2026)
Puma Biotechnology (PBYI) recorded Net Margin of 14.49% in Q2 2026, up 3.33 percentage points from 11.17% a year earlier and up 22.97 percentage points from the prior quarter.
Puma Biotechnology (PBYI) Net Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Puma Biotechnology's Net Margin came in at 11.52% as of Jun 30, 2026, down 8.83 percentage points year-over-year; for FY2025, it was 13.62%, up 0.49 percentage points from FY2024.
- Annual Net Margin has increased for eight straight years, with a five-year change of +40.27 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 13.14% in FY2024 (+3.97 pp), 9.16% in FY2023 (+9.16 pp), 0.00% in FY2022 (+11.51 pp) and -11.51% in FY2021 (+15.15 pp).
- Quarterly Net Margin has ranged from -96.60% in Q3 2021 to 32.68% in Q4 2024 over the past five years.
- On a year-over-year basis, Net Margin rose in five of the last eight quarters, with an average year-over-year change of +4.16 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 95.97 percentage points in Q3 2022, against a drop of 34.61 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -8.48% (Q1 2026), 17.77% (Q4 2025) and 16.23% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 10.82% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.82% |
| Jun 30, 2026 | 14.49% |
| Mar 31, 2026 | -8.48% |
| Dec 31, 2025 | 17.81% |
| Sep 30, 2025 | 16.23% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 6.46% |
| Dec 31, 2024 | 32.68% |
| Sep 30, 2024 | 25.23% |
| Jun 30, 2024 | -9.62% |
| Mar 31, 2024 | -11.00% |
| Dec 31, 2023 | 17.00% |
| Sep 30, 2023 | 10.33% |
| Jun 30, 2023 | 3.90% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | -8.54% |
| Sep 30, 2022 | -0.63% |
| Jun 30, 2022 | 15.74% |
| Mar 31, 2022 | -7.44% |
| Dec 31, 2021 | 7.63% |
Puma Biotechnology Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();